ストックスクリーナーアプリを入手
11.15
4.46%
-0.51
前日終値:
$11.66
開ける：
$12.19
24時間の取引高:
210.13K
Relative Volume:
0.07
時価総額：
$17.65M
収益：
$74,000
当期純損益:
$-13.43M
株価収益率:
-1.1862
EPS:
-9.4
ネットキャッシュフロー:
$-10.54M
1週間 パフォーマンス:
-9.65%
1か月 パフォーマンス:
+3,168%
6か月 パフォーマンス:
+97.13%
1年 パフォーマンス:
-57.80%
1日の値動き範囲:
$11.03
$13.39
1週間の範囲:
$7.5101
$18.00
52週間の値動き範囲:
$0.215
$39.84
Cyclacel Pharmaceuticals Inc Stock (CYCC) Company Profile
名前
Cyclacel Pharmaceuticals Inc
セクター
電話
908-517-7330
住所
200 CONNELL DRIVE, BERKELEY HEIGHTS, NJ
CYCC を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
CYCC
Cyclacel Pharmaceuticals Inc
|
11.14 | 5.24M | 74,000 | -13.43M | -10.54M | -9.40 |
|
VRTX
Vertex Pharmaceuticals Inc
|
465.51 | 121.30B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
556.73 | 61.60B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
322.25 | 41.17B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
569.31 | 34.35B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
292.31 | 27.29B | 3.81B | -644.79M | -669.77M | -6.24 |
Cyclacel Pharmaceuticals Inc Stock (CYCC) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2022-07-18 | 再開されました | Oppenheimer | Outperform |
| 2020-04-27 | 再開されました | ROTH Capital | Buy |
| 2018-09-07 | 開始されました | Ladenburg Thalmann | Buy |
| 2015-10-16 | 開始されました | H.C. Wainwright | Buy |
| 2010-02-04 | 開始されました | Roth Capital | Buy |
| 2009-10-28 | 開始されました | Merriman | Buy |
| 2008-08-12 | 開始されました | Piper Jaffray | Buy |
| 2008-03-12 | 繰り返されました | Cantor Fitzgerald | Buy |
| 2008-03-12 | 繰り返されました | Collins Stewart | Buy |
| 2008-03-12 | 繰り返されました | Needham & Co | Buy |
| 2007-11-27 | 繰り返されました | Cantor Fitzgerald | Buy |
| 2007-08-10 | 繰り返されました | Cantor Fitzgerald | Buy |
| 2007-06-04 | 繰り返されました | Needham & Co | Buy |
| 2007-04-23 | 開始されました | Lazard Capital | Buy |
| 2007-04-10 | 開始されました | Cantor Fitzgerald | Buy |
すべてを表示
Cyclacel Pharmaceuticals Inc (CYCC) 最新ニュース
Is Cyclacel Pharmaceuticals Inc. a good long term investmentRemarkable growth - jammulinksnews.com
What makes Cyclacel Pharmaceuticals Inc. stock price move sharplyFree Stock Index Interpretation - Newser
What analysts say about Cyclacel Pharmaceuticals Inc. stockExceptional financial outcomes - jammulinksnews.com
What drives Cyclacel Pharmaceuticals Inc. stock priceSignificant capital appreciation - jammulinksnews.com
CYCC’s Financial Health: Exploring Cyclacel Pharmaceuticals Inc’s Debt-to-Equity Ratio of 1.79 - investchronicle.com
Cyclacel Plunges 11.09% on Revenue Guidance Cut - AInvest
Wall Street Zen Downgrades Cyclacel Pharmaceuticals (NASDAQ:CYCC) to Sell - Defense World
Cyclacel Pharmaceuticals Inc. Stock Analysis and ForecastHigh-octane financial growth - jammulinksnews.com
CYCLACEL PHARMACEUTICALS INC 6% CNV PFD USD To Go Ex-Dividend On July 21st, 2025 With 0.15 USD Dividend Per Share - 富途牛牛
Big Moves And Bigger Questions For Biotech And Tech Stocks - Finimize
Cyclacel stock falls after paring 270% gain amid volatility concerns By Investing.com - Investing.com Canada
Cyclacel stock dips after trimming 270% surge amid volatility concerns - MSN
Cyclacel Shares Plunge 36% Amid Volatility, What's Driving the Sell-Off? - AInvest
Cyclacel stock falls after paring 270% gain amid volatility concerns - Investing.com Australia
Cyclacel Pharmaceuticals Addresses Recent Stock Price Volatility Amid Ongoing Business Developments - Quiver Quantitative
CYCLACEL PHARMACEUTICALS COMMENTS ON RECENT STOCK PRICE VOLATILITY - Yahoo Finance
Cyclacel Pharmaceuticals Stock Plunges 37.23% - AInvest
Cyclacel Pharmaceuticals Stock Surges Amid Positive Research Findings - AInvest
Why Cyclacel Pharmaceuticals Inc. stock attracts strong analyst attentionExpert Backed Predictions - Newser
Why Is Cyclacel Pharmaceuticals Stock Soaring On Tuesday? - Benzinga
Cyclacel's Volatile Surge: Can This Biotech Stock Defy Gravity? - AInvest
Cyclacel Pharmaceuticals Stock Soars: Investing or Waiting? - timothysykes.com
Cyclacel Pharmaceuticals (NASDAQ:CYCC) Upgraded by Wall Street Zen to “Hold” Rating - Defense World
Fitters: US$1m cash added to Cyclacel deal to address stock volatility since signing - The Malaysian Reserve
Cyclacel Stock Surges 50% After Amending Exchange Agreement with FITTERS - MSN
Cyclacel stock soars after amendment to exchange agreement with FITTERS By Investing.com - Investing.com Nigeria
Cyclacel stock soars after amendment to exchange agreement with FITTERS - Investing.com Australia
Cyclacel sweetens Fitters acquisition deal with US$1m cash addition - The Malaysian Reserve
Cyclacel Pharmaceuticals Amends Exchange Agreement with FITTERS - TipRanks
CYCLACEL PHARMACEUTICALS HIGHLIGHTS PUBLICATION OF PRECLINICAL DATA SHOWING THAT PLOGOSERTIB IS ACTIVE IN A HARD-TO-TREAT SUBTYPE OF LIVER CANCER - The Manila Times
Breakthrough: New Drug Shows Effectiveness Against Untreatable Youth Liver Cancer, Research Reveals - Stock Titan
Cyclacel Pharmaceuticals adjusts shareholder rights, amends stock - MSN
Cyclacel Pharmaceuticals to Acquire Fitters Sdn. Bhd. Through Share Exchange Agreement - Global Legal Chronicle
Cyclacel Pharmaceuticals Announces 1-for-15 Reverse Stock Split Effective July 7, 2025 - Nasdaq
Cyclacel Pharmaceuticals Announces Stock Split - Morningstar
Cyclacel Announces Major Share Restructuring: 23.7M Shares Consolidating to 1.58M - Stock Titan
Cyclacel Pharmaceuticals shareholders re-elect directors and approve equity plan changes - Investing.com India
Cyclacel Pharmaceuticals Inc (CYCC) 財務データ
収益
当期純利益
現金流量
EPS
0.14%
0.65%
大文字化:
|
ボリューム (24 時間):